The Brain Tumor Cooperative Group NIH Trial 87-01: a randomized comparison of surgery, external radiotherapy, and carmustine versus surgery, interstitial radiotherapy boost, external radiation therapy, and carmustine.
about
The evolving roles and controversies of radiotherapy in the treatment of glioblastomaInterstitial chemotherapy with biodegradable BCNU (Gliadel) wafers in the treatment of malignant gliomas.Radiotherapeutic alternatives for previously irradiated recurrent gliomas.Stereotactic radiosurgery versus fractionated stereotactic radiotherapy boost for patients with glioblastoma multiforme.Survival following CyberKnife radiosurgery and hypofractionated radiotherapy for newly diagnosed glioblastoma multiforme.Patients with high-grade gliomas harboring deletions of chromosomes 9p and 10q benefit from temozolomide treatment.Hyperthermia Sensitizes Glioma Stem-like Cells to Radiation by Inhibiting AKT Signaling.Concurrent temozolomide and dose-escalated intensity-modulated radiation therapy in newly diagnosed glioblastomaPrognostic factors for survival of patients with glioblastoma: recursive partitioning analysisMetallofullerene-nanoplatform-delivered interstitial brachytherapy improved survival in a murine model of glioblastoma multiformeSurgical management of high-grade gliomas.Hypofractionated radiotherapy for glioblastoma: strategy for poor-risk patients or hope for the future?Chemotherapy in the treatment of malignant gliomas.Ionizing radiation in glioblastoma initiating cells.Photon radiotherapy for the treatment of high-grade gliomas.Present trend in the primary treatment of aggressive malignant glioma: glioblastoma multiforme.Randomized Phase III controlled trials of therapy in malignant glioma: where are we after 40 years?Irradiation of pediatric high-grade spinal cord tumors.Feasibility and outcomes of hypofractionated simultaneous integrated boost-intensity modulated radiotherapy for malignant gliomas: a preliminary report.Integrated-boost IMRT or 3-D-CRT using FET-PET based auto-contoured target volume delineation for glioblastoma multiforme--a dosimetric comparison.Current available therapies and future directions in the treatment of malignant gliomas.Molecular pathways and potential therapeutic targets in glioblastoma multiforme.Salvage Fractionated Stereotactic Radiotherapy with or without Chemotherapy and Immunotherapy for Recurrent Glioblastoma Multiforme: A Single Institution Experience.Launching Effectiveness Research to Guide Practice in Neurosurgery: A National Institute Neurological Disorders and Stroke Workshop Report.The role of brachytherapy in the treatment of glioblastoma multiforme.Management of GBM: a problem of local recurrence.Stereotactic iodine-125 brachytherapy for brain tumors: temporary versus permanent implantation.Combined modality approaches in the management of adult glioblastoma.Injectable Hydrogels for Localized Chemotherapy and Radiotherapy in Brain Tumors.Immediate post-operative brachytherapy prior to irradiation and temozolomide for newly diagnosed glioblastoma.Patients Affected by Unmethylated O(6)-Methylguanine-DNA Methyltransferase Glioblastoma Undergoing Radiochemotherapy May Benefit from Moderately Dose-Escalated Radiotherapy.Implantable systems for drug delivery to the brain.Results of phase I study of a multi-modality treatment for newly diagnosed glioblastoma multiforme using local implantation of concurrent BCNU wafers and permanent I-125 seeds followed by fractionated radiation and temozolomide chemotherapy.Stereotactic brachytherapy using iodine 125 seeds for the treatment of primary and recurrent anaplastic glioma WHO° III.Simultaneous integrated vs. sequential boost in VMAT radiotherapy of high-grade gliomas.Radiotherapy of Glioblastoma 15 Years after the Landmark Stupp’s Trial: More Controversies than Standards?
P2860
Q26746622-78A8BE24-3A32-41F2-8F1D-6ADDF07F6B35Q30441811-AAF8A208-E109-470F-9ACA-4944D65889E5Q30497184-AC47BBCB-7F8B-42B2-8C65-2D9D5F2DA329Q33197247-E532CD2A-97EE-440A-B942-905260F83385Q33333892-27D34583-4E8C-481C-9927-6539BBC55A07Q34769937-F41E6BF8-73FC-439B-8002-9960F79DEBF0Q35463653-B3554BF9-4D1F-4378-856E-B0E522245C5DQ35699156-57E40C53-B6A0-4A52-8F2A-D207F41E8684Q35800783-1F6CBBBC-1B13-4ECB-90BB-0236C73D53DCQ36251215-B00EF42C-3596-47FD-8AD7-06064F8823E8Q36307798-27367AB7-8F37-492F-8EA5-447FBF214A05Q36365570-1376A206-D5EB-4E6B-B18F-0ED5D020C5A3Q36499238-3E088938-A65D-4AE9-9DA6-C7524031D0DEQ36746959-E32BF20F-5DB9-4EF3-A93A-28A6D46765C3Q37030808-5E3CE44B-AC0E-4E3B-B482-A4AF1FE1572BQ37160479-C6680966-E95A-416F-BE90-7E36D681D8A8Q37196375-1C967253-B2AB-48AB-B3F7-8CC3E77EA3ACQ37394315-CC1D4CD9-0AD5-4220-9D19-F45EEBCC6CC1Q37418864-EBC45DBC-D8D6-47B7-B77D-54338F9345BEQ37455074-03B43596-4CD5-4033-9826-DCD0130E4B43Q37586907-6C085426-75B9-4E4F-9A0D-959C1C6A9149Q38156191-070A2632-C5FC-4569-B1CC-0722B5F5FAD3Q38510365-4845570F-BBDB-442E-AEF7-450E291B8AF7Q38737166-32CCC326-0526-4C27-8B5E-D649B9972BC0Q38834847-5740C41D-48CA-4FE3-B052-E7A322F995E7Q39220867-1285F4C6-0356-494A-B1AF-078A4E53495AQ39599875-BB3F752C-E27C-47CA-8859-0A19BD02C04DQ42151501-5E9D6FE9-1498-402B-A143-9CDDE1C69A23Q46802657-F6B369D5-2779-423E-9BBF-4CAE987C1C2AQ46857246-3F46168F-075A-4A42-8748-DE3BFD6A4F88Q47094808-5A77AD56-0D2C-47C7-AD64-06D53AC76BD5Q47975817-1E397E74-0FA8-4871-A3BF-E80B8258F217Q48587894-B4FDABAA-B75B-480C-A536-1420A9D94D1FQ51765108-868CD6C3-B8FF-44B1-AB06-E963E253233AQ52149946-962EC7FE-BEA4-4184-90E4-B7BB35A1310EQ55711736-76C0DCD3-D050-42B9-9360-06E9018871FE
P2860
The Brain Tumor Cooperative Group NIH Trial 87-01: a randomized comparison of surgery, external radiotherapy, and carmustine versus surgery, interstitial radiotherapy boost, external radiation therapy, and carmustine.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The Brain Tumor Cooperative Gr ...... ation therapy, and carmustine.
@ast
The Brain Tumor Cooperative Gr ...... ation therapy, and carmustine.
@en
The Brain Tumor Cooperative Gr ...... ation therapy, and carmustine.
@nl
type
label
The Brain Tumor Cooperative Gr ...... ation therapy, and carmustine.
@ast
The Brain Tumor Cooperative Gr ...... ation therapy, and carmustine.
@en
The Brain Tumor Cooperative Gr ...... ation therapy, and carmustine.
@nl
prefLabel
The Brain Tumor Cooperative Gr ...... ation therapy, and carmustine.
@ast
The Brain Tumor Cooperative Gr ...... ation therapy, and carmustine.
@en
The Brain Tumor Cooperative Gr ...... ation therapy, and carmustine.
@nl
P2093
P1433
P1476
The Brain Tumor Cooperative Gr ...... ation therapy, and carmustine.
@en
P2093
Brain Tumor Cooperative Group
Emile Hiesiger
Fred H Hochberg
James T Robertson
Jeffrey Olson
John C Gilder
John H Neal
John J Mealey
Margaret S Blackwood
Mark G Malkin
P304
343-55; discussion 355-7
P356
10.1097/00006123-200208000-00009
P407
P577
2002-08-01T00:00:00Z